When DSO executives evaluate AI-powered diagnostic imaging, Overjet and VideaHealth consistently appear on shortlists. Both are venture-backed, FDA-cleared, and focused on transforming how dental radiographs are read and acted upon. Yet they come at the problem from different angles, with distinct research foundations, insurance strategies, and clinical feature sets. Here is what matters for DSO decision-makers weighing these two platforms.
Overview
Overjet emerged from MIT and Harvard research labs in 2018, building a platform that serves both clinical practices and insurance carriers. The company has secured multiple FDA 510(k) clearances for detecting caries, measuring bone loss, and analyzing dental restorations. Its dual-market approach, serving both payers and providers, is a defining strategic characteristic. Overjet has raised over $100 million and counts major carriers and large DSOs among its customers.
VideaHealth, also born from academic research with roots in MIT’s Computer Science and Artificial Intelligence Laboratory, has positioned itself as a clinically focused dental AI platform. VideaHealth holds FDA clearance for its diagnostic AI and has published peer-reviewed research on its algorithms’ performance. The company has raised substantial venture capital and has expanded its deployments across dental groups and DSOs, with a particular emphasis on improving diagnostic accuracy and reducing missed pathology at the chair.
Overjet Strengths
- Payer-provider network — Overjet is the only major dental AI platform operating on both sides of the claims process. When a DSO’s insurance partners also use Overjet for claim adjudication, there is an inherent alignment that can reduce denials and accelerate reimbursement.
- Multiple distinct FDA clearances — Overjet holds separate clearances for caries detection, bone loss quantification, and restorations analysis, providing a broad and independently validated regulatory portfolio.
- Quantitative periodontal data — Overjet’s bone loss measurement provides millimeter-level and percentage-based readings, which is particularly valuable for perio-focused DSOs that need defensible documentation for treatment plans and insurance submissions.
- Insurance claim automation — Beyond clinical decision support, Overjet’s payer platform automates radiograph review for claim validation, which can benefit DSOs indirectly through faster processing by participating carriers.
VideaHealth Strengths
- Deep academic research foundation — VideaHealth’s algorithms are grounded in peer-reviewed research, with published studies demonstrating improved diagnostic accuracy when dentists use the AI as a second reader. The company has invested heavily in clinical validation studies showing its AI can help clinicians catch conditions they might otherwise miss.
- Focus on diagnostic lift — VideaHealth emphasizes measurable improvements in diagnostic yield, reporting that practices using the platform see meaningful increases in the detection of early-stage caries and other pathology that might be overlooked in busy clinical settings.
- Clinical workflow integration — VideaHealth has designed its interface to fit seamlessly into existing clinical workflows, providing AI annotations directly alongside the radiograph at the point of diagnosis without requiring clinicians to switch between applications.
- Treatment planning support — Beyond detection, VideaHealth aims to support the full diagnostic-to-treatment pathway, helping clinicians not just identify pathology but also communicate findings to patients and build appropriate treatment plans.
Head-to-Head Comparison
Research and Clinical Validation: Both companies have strong academic pedigrees and peer-reviewed publications supporting their technology. Overjet has published on caries detection and bone loss measurement accuracy, while VideaHealth has focused on demonstrating diagnostic lift, showing how much AI assistance improves clinician performance versus unassisted diagnosis. For evidence-driven DSOs, both provide credible clinical data, though VideaHealth’s focus on before-and-after diagnostic improvement metrics may resonate more with clinical leadership.
Insurance Integration: This is where the two platforms diverge most sharply. Overjet operates a full payer-side platform that processes claim radiographs for major dental insurers. VideaHealth is primarily a clinical tool and does not have a comparable payer-side offering. For DSOs where claim processing efficiency and payer alignment are top priorities, Overjet has a clear structural advantage. For DSOs focused purely on chairside diagnostic quality, this difference may be less relevant.
Clinical Features: Overjet excels in quantitative analysis, particularly its millimeter-level bone loss measurements that translate directly into periodontal documentation. VideaHealth places more emphasis on the overall diagnostic experience, with AI annotations designed to improve the clinician’s ability to detect a range of pathologies including early caries. Both detect caries and support general diagnostic workflows, but their emphasis areas differ.
Enterprise Readiness: Both platforms have demonstrated the ability to deploy across multi-location dental organizations. Overjet’s larger funding base and payer relationships give it an edge in pure scale. VideaHealth has been growing its DSO footprint rapidly and offers enterprise features including centralized management and reporting. DSOs should evaluate both on their ability to integrate with existing PMS and imaging systems at the specific locations in question.
Which One Should Your DSO Choose?
If your DSO’s strategic priorities include insurance workflow optimization, payer alignment, and quantitative periodontal documentation, Overjet is the natural fit. Its dual-market model creates value that extends beyond the operatory into the billing office and beyond. This is particularly true if your primary insurance partners are already using Overjet for claim review.
If your DSO’s top priority is maximizing chairside diagnostic accuracy, reducing missed pathology, and equipping clinicians with research-backed AI that demonstrably improves detection rates, VideaHealth deserves serious consideration. Its focus on diagnostic lift and clinical workflow integration makes it well suited for organizations where clinical quality improvement is the driving motivation for adopting AI.
Both vendors support pilot programs, and a structured evaluation period at two to three locations with clear success metrics is the most reliable path to a confident enterprise decision.
Bottom Line
Overjet and VideaHealth represent two strong but strategically different approaches to dental AI. Overjet is the broader ecosystem play, connecting clinical diagnostics to insurance workflows in a way no competitor matches. VideaHealth is the deeper clinical play, focused on making every dentist a better diagnostician. DSOs that understand their own primary use case, whether it is payer alignment and operational efficiency or clinical quality and diagnostic accuracy, will find the choice between these two platforms relatively clear. For those where both priorities carry equal weight, a dual-pilot approach is the smartest investment before committing.